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Abstract 
Background: Arteriovenous 
malformations (AVMs) are congenital 
lesions requiring multimodal approach.  
Method: We report a case of a 25 years 
old woman, with ruptured temporobasal 
AVM, who required multimodal treatment, 
emphasizing on treatment options, 
advantages and disadvantages of each 
treatment chosen, encountered difficulties, 
technical considerations and outcome.  
Results: The patient, admitted for the 
first time in comatose state, underwent 
emergent surgery with evacuation of an 
intraparenchymatal hematoma and 
decompressive craniectomy. After 
neurological recovery, the patient was 
thoroughly investigated and positive 
diagnosis of left temporobasal AVM was 
established. The patient underwent surgery 
with subtotal resection of the AVM, 
followed by Gamma knife stereotactic 
radiosurgery of the residual nidus. The 
outcome was favorable.   
Conclusions: AVMs need complex 
treatment performed in a multidisciplinary 
team. Surgery is the treatment of choice in 
management of the AVMs. Gamma knife 
stereotactic surgery is required if a residual 
nidus is left in place following surgery. 
Definitive treatment in AVMs is mandatory 
because of the high risks of hemorrhage 
with high morbidity and mortality.    
Keywords: arteriovenous malformation, 
AVM surgery, residual nidus, stereotactic 
radiosurgery 
Introduction 
Arteriovenous malformations (AVMs) 
are congenital lesions composed of a 
complex tangle of dysplasic arteries and 
arterialized veins connected by shunts. 
Within the abnormal conglomerate of 
vessels, called nidus, blood is drained 
through feeding arteries directly into 
draining veins, without any capillary bed. 
Arteries have a deficient muscularis layer 
and red draining veins are dilated and 
contain high flow oxygenated blood.  
AVMs were described for the first time 
by Luschka and Virchow in the mid 1800s 
and Olivecrona performed the first surgical 
excision of an AVM in 1932. (1)  
It is difficult to estimate the real 
incidence of AVMs, it usually ranges 
between 0.15 and 3%. (18, 26) Prevalence is 
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0.14%. (1, 9) AVMs represent 6% of 
intracranial lesions. The average age at 
diagnostic is 33 years, and 64% of AVMs are 
diagnosed before age 40. (9, 20) AVMs are 
the main cause of hemorrhagic strokes in 
young patients. (8)  
The two main clinical presentation 
forms are rupture of the AVM with 
consequent hemorrhage 
(intraparenchymatal, intraventricular or 
subarachnoidian bleeding) and seizures. 
Other clinical manifestations are 
progressive neurological deficit secondary 
to the vascular steal phenomenon from de 
adjacent brain, hydrocephalus due to 
venous hypertension in the draining veins, 
neurological deficits secondary to mass 
effect of an enlarging AVM and increased 
intracranial pressure. 
Treatment options of AVMs consist of 
surgery, endovascular embolization, 
stereotactic surgery or multimodal 
approach. Treatment must be 
individualized according to neurologic state 
at admission, general state, co-morbidities, 
age, characteristics of the AVM and 
therapies available in the hospital of 
admission. 
Method 
We report a case of a left temporobasal 
AVM treated into the Forth Department of 
Neurosurgery. We reviewed medical 
records, imaging, treatment and follow-up. 
Patient BS, woman, 25 years old, with no 
significant previous history prior current 
episode, was transferred from another 
department on the 29th of October 2009 
with the following diagnostic: ruptured 
profound left temporal AVM. 
History: sudden onset 8 days before 
admission in our department, with 
headache, vomiting and impaired 
consciousness. Patient was admitted in 
emergency in another department of 
neurosurgery with comatose state, GCS 6 
points and right hemiparesis. Emergency 
CT scan showed a left 
frontotemporoparietal intraparenchymatal 
hematoma. Patient underwent emergent 
surgery, hematoma was evacuated and 
decompressive craniectomy was performed. 
Two days after surgery a 4 vessel 
angiography was performed which revealed 
a profound left temporobasal AVM. Patient 
was redirected to our department for 
further treatment. 
On admission the patient presented 
impaired consciousness, GCS 9 points (M5, 
V2, O2), had right hemiparesis, hyperactive 
deep tendon reflexes right > left and 
bilateral Babinski sign. The cerebral CT 
scan revealed postoperatory left temporal 
hipodensity, intraventricular hemorrhage 
(within both lateral ventricles) and 
decompressive craniectomy (Figure 1).    
Cerebral IRM showed a left 
temporohippocampal AVM, with 
consequent involvement of left internal 
capsule and thalamus, with feeding arteries 
from left middle cerebral artery and left 
posterior cerebral artery and venous 
drainage into left transverse sinus (Figure 
2).  
Four vessels cerebral DSA (digital 
subtraction angiography) showed a left 
capsulothalamic AVM grade III Spetzler-
Martin, with nidus measuring 3 cm in 
diameter, with feeding arteries from 
talamostriate arteries from left posterior 
communicating artery and left posterior 
cerebral artery, anterior choroidal artery and 
perforating branches from left segment M1 
of the middle cerebral artery (Figure 3). 
Pulmonary X-ray and 
electrocardiography were normal. 
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Figure 1 Cerebral CT scan, left temporal hipodensity, intraventricular hemorrhage, decompressive craniectomy 
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Figure 2 Cerebral IRM T2, left temporohippocampal AVM involving left internal capsule with feeding arteries 
from left middle cerebral artery and left posterior cerebral artery 
 
 
Figure 3 Four vessels DSA, left internal corotid artery, left capsulothalamic AVM with nidus measuring 3 cm in 
diameter, with feeding arteries from talamostriate arteries from left posterior communicating artery and left 
posterior cerebral artery, anterior choroidal artery and perforating branches from left segment M1 of the middle 
cerebral artery 
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Results 
She received Dexamethasone 16 mg/d, 
Mannitol 20% 250 ml/d, Furosemid 40 
mg/d, antiepileptic drugs, analgesics and 
intravenous hydration. 
Neurological outcome was favorable, the 
patient regained consciousness, GCS 14 
points, had severe right hemiparesis and 
dysphasia.  
In order to determine whether 
intraarterial embolization was a valid option 
we asked for an interventional 
neuroradiology consult which 
contraindicated embolization because the 
AVM had no pedicles that can be 
catheterized with microcathethers of the 
equipment. 
Gamma knife stereotactic radiosurgery 
was also contraindicated because the nidus 
includes the middle cerebral artery and 
comes into contact with left optic 
radiations.  
Pre-anesthetic consult found a risk score 
ASA IV and anemia (Hg=8.6 g/dl). 
On the 9th of November 2009 the 
patient underwent surgery. The patient was 
position supine, with roll under her left 
shoulder. The head was turned 45° to the 
right. We reopened the wound on the 
previous skin incision for left temporal 
bone flap and we incised the neodura mater 
in a stellate fashion. We performed opening 
of the left sylvian fissure, with visualization 
of the left middle cerebral artery and sylvian 
artery trifurcation. A tangle of vessels 
(nidus) was discovered in close vicinity 
with middle cerebral artery, surrounding it. 
The nidus was dissected free from the 
middle cerebral artery, which was left 
intact. Left internal carotid artery and left 
anterior choroidal artery were found and 
spared. A vascular clip was put on the 
feeding artery arising from left posterior 
cerebral artery. Subtotal removal of the 
AVM was performed, the part situated in 
the vicinity of the left middle cerebral 
artery. We copious irrigated the operative 
field with normal saline and performed 
carefully hemostasis. At the end of the 
operation normal brain pulsation were 
noticed. We performed wound closure with 
watertight duraplasty with pericranium and 
anchoring of dura mater, epidural drain, 
replacement and fixation of the bone flap 
conserved from previous surgery and skin 
suture.  
The patient was extubated and awaked in 
the operating room. Immediate 
postoperatory examination revealed: 
efficient spontaneous breathing, right 
hemiparesis and dyphasia. The patient was 
taken to intensive care unit. The epidural 
drain was pulled out after 48 hours. During 
the following days dysphasia slowly 
recovered. Postoperatory outcome was 
favorable, the patient regained 
consciousness, GCS 15 points, she had 
right hemiparesis and presented no aphasia.  
Histopathological exam confirmed the 
diagnosis of racemous hemangioma 
(arteriovenous malformation). 
Postoperatory CT scan was normal 
(Figure 4). 
Postoperatory 4 vessels DSA showed the 
residual nidus (Figure 5). 
On 2nd of March 2010 (5 months after 
surgery) the patient was admitted for 
stereotactic irradiation of the residual nidus. 
Gamma knife stereotactic radiosurgery was 
performed, using a marginal dose of 18.5 
Gy at the 60% isodose line, on a target 
volume of 1.4 cm3. Total irradiation dose 
was 0.7 Gy (1.3 J). Postirradiation outcome 
was favorable. 
Four vessels DSA performed in June 
2011, 16 months after stereotactic 
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radiosurgery, revealed complete obliteration 
of the residual nidus (Figure 6). Long term 
follow-up CT scan showed a normal 
postoperatory aspect (Figure 7). 
Neurological examination found right 
hemiparesis and no aphasia. The patient 
presented no seizure under Fenobarbital 
100 mg/d. She was included in a 
kinetotherapy intensive program. 
 
 
 
 
 
 
 
 
Figure 4 Cerebral CT scan, normal postoperatory 
aspect 
 
 
Figure 5 Four vessel DSA, left internal corotid 
artery, residual nidus 
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Figure 6 Four vessel DSA, left internal corotid 
artery, residual nidus obliteration 
 
 
 
 
 
 
Figure 7 Cerebral CT scan, long term follow-up, 
normal postoperatory aspect 
Discussions 
The patient had a typical sudden onset of 
ruptured AVM. Hemorrhage is the most 
common form of presentation, 50-70% of 
patients harboring such malformations 
present with bleeding. (9, 12, 24) Bleeding 
occur most commonly intraparenchymatal, 
intraventricular, usually concomitant with 
intracerebral hematoma as a result of 
rupture into ventricles or pure 
intraventricular or rarely subarachnoid or 
subdural. (9) The patient had no history of 
seizure. Usually patients having seizure are 
investigated and the AVM is diagnosed 
before rupture.  
Increasing age, initial rupture of the 
AVM, deep brain location and exclusive 
deep venous drainage are independent 
predictors of subsequent hemorrhage. 
Annual hemorrhage rates on follow-up 
ranged from 0.9% for patients without 
bleeding to 34.4% in people with ruptured 
and deep AVMs and with deep venous 
drainage. (6, 7, 27) Hemorrhage carries a 
10% mortality and 30-50% morbidity rates 
with each bleed. (9)  
The patient was admitted in emergency 
in another neurosurgical department. The 
first surgery was performed in order to save 
her life, this is why only evacuation of the 
intraparenchymatal hematoma and 
decompressive craniectomy for brain 
swelling were performed.  
Although the postoperatory outcome was 
favorable, and the patient had no further vital 
risk, an ethiopathogenic treatment was 
mandatory. (6) She was transferred in our 
department for definitive treatment. The 
need for an ethiopathogenic treatment is 
sustained by risks of further rupture.  
The risk of hemorrhage from an AVM is 
2-4% per year, therefore the risk of bleeding 
over the entire life is very high. (9) The risk 
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of bleeding is calculated with the following 
formula: 
 
Risk of bleeding (at least once) = 1 – (annual 
risk of not bleeding)expected years of remaining life 
The annual risk of not bleeding is 1- 
annual risk of bleeding. 
In our patient aged 25, with expected 52 
tears to live, for an average risk of 
hemorrhage of 3% per year, the total risk of 
bleeding at least once is 79%. (9)  
More, the risk of bleeding during the 
first year after primary rupture is 6%. (16) 
The risk deceases over the next years, but 
remains significant for decades.   
Risk of bleeding is higher in AVMs with 
previous rupture, deep and infratentorial 
locations. (12, 19)  
At admission in our department the 
situation is different, because her life is not 
in danger and she could be thoroughly 
investigated prior definitive treatment. 
Treatment options of AVMs, all available 
in our department, consist of surgery, 
endovascular embolization, stereotactic 
radiosurgery and multimodal treatment. (6)  
In 1986 Spetzler and Martin proposed a 
grading system of AVMs, based on size of 
AVM, eloquence of adjacent brain and 
pattern of venous drainage. (25) Spetzler-
Martin grading system is helpful in 
predicting surgical risk. (9, 16, 29) While in 
patients harboring  grade I and II surgical 
risk is low, patients with grade III AVMs 
represent a more challenging decision-
making dilemmas, because they carry a 
significant higher surgical risk. (16) In the 
algorithm of decision-making we must take 
into account other factors such as ruptured 
vs. nonruptured AVM, clinical presentation, 
patient’s age and co-morbidities.  
Embolization can be used as single 
treatment or as neoadjuvant for surgery or 
stereotactic surgery. In order to be done it 
requires an interventional neuroradiology 
department with trained personnel. 
Embolization is a minimally invasive 
procedure and when used as a neoadjuvant 
technique it facilitates surgery, by reducing 
the volume of the malformation, decreasing 
the intraoperative bleeding, occluding deep 
or difficult to reach feeding arteries and 
associated aneurysms outside the operative 
field. (10, 28) Using embolization alone the 
rate of complete occlusion is only 10%, and 
even in completed occluded AVMs the 
recanalization reaches 50%, but 
endovascular techniques reduce the volume 
of the malformation with 75%. (10) Surgery 
must be performed within 3-30 days after 
embolization. If patient becomes 
symptomatic and he has no intracranial 
lesion requiring emergent surgery, the 
operation is postponed until he recovers. 
(9) Morbidity and mortality rates following 
embolization are low. (5, 11, 13, 14) 
Mortality is 1% and morbidity is 3.9%. (5, 
11, 22) Long-term permanent neurologic 
deficits are encountered in 8.6% of patients. 
(14) Immediately following procedure, 
significant neurological complications 
occurred in 2.7-7.1%, yet a majority of 
deficits improve or resolve over time. (22, 
28) Embolization carries a procedural risk 
related to AVM’s grade and number of 
occluded branches. (14) 
Unfortunately microcathethers of the 
equipment were unable to catheterize the 
feeding pedicles. The AVM had feeding 
arteries from talamostriate arteries arising 
from left posterior communicating artery 
and left posterior cerebral artery, anterior 
choroidal artery and perforating branches 
from left segment M1 of the middle 
cerebral artery. Catheterization of such 
small branches requires very small catheters 
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and carries a significant risk of improper 
embolization of the parental artery with 
post procedural morbidity. The answer to 
this problem is acquisition of smaller 
catheters.  
Stereotactic radiosurgery is used in small 
AVMs, with nidus measuring 2.5-3 cm. 
Stereotactic radiosurgery include Gamma 
knife radiosurgery, proton beam 
radiosurgery, and linear accelerators 
(LINAC). Advantages of stereotactic 
radiosurgery are: it is a non invasive 
procedure and it can be done in an 
ambulatory patient.  
Principle of radiosurgery consists of 
directing radiation with narrow beam 
particles, consisting of 201 converged 
sources, given in a single session, to a 
predetermined target volume, with 
minimum risk of damage to surrounding 
brain. 
Stereotactic radiosurgery causes gradual 
obliteration of the nidus. Radiation of 
vessels causes proliferation of smooth-
muscle cells and increases extracellular type 
IV collagen producing, which leads to 
progressive stenosis and obliteration of the 
nidus and, in the end, to cellular 
degeneration and hyaline transformation. 
(4, 23) Because of the delayed obliteration 
of AVMs after radiosurgery, comprehensive 
long-term management and observational 
strategies are necessary. The risks associated 
with AVMs, including the risk of bleeding, 
persist during this period of time, therefore 
until obliteration the lesion cannot be 
considered cured. Obliteration of the 
AVMs following stereotactic radiosurgery 
occurs late, after 1-3 years following initial 
procedure. (4, 9) Imaging follow-up are 
recommended at six month intervals for the 
first three years to assess the effect of 
radiosurgery on AVM. Another 
disadvantage of stereotactic irradiation is the 
fact that it is limited to lesions measuring 
maximum 3 cm in diameter.   
If obliteration does not occur after 3 years, 
the irradiation can be safely repeated. (15)  
Dose planning is based on location and 
volume of the AVM and relation with the 
surrounding structures. Marginal doses 
typically range from 16 to 25 Gy in a single 
fraction. 
Although the nidus measured 3 cm in 
diameter Gamma knife stereotactic surgery 
was contraindicated because of the relation 
of the nidus with the middle cerebral artery 
and left optic radiation. Inclusion of the 
middle cerebral artery into the target 
volume can lead to radiation artery wall 
lesions with stenosis and occlusion. Also 
vicinity of optic radiations limits using 
stereotactic surgery. Tolerable dose to the 
optic radiation is 8 Gy, a dose similar to 
anterior optic pathways. (17) 
Surgery is the treatment of choice, 
because if complete resection can be 
performed provides cure of the 
malformation. (7) Total resection cannot be 
always done. Causes that can prevent total 
excision are: anesthetic problems during 
surgery (patients develop cardiocirculatory 
instability, e.g. bradycadia, hypotension), 
high grade Spetzler-Martin AVMs (staged 
surgery is a solution for these cases), 
portion of the nidus located in eloquent 
areas, deep nidus with deep feeding arteries 
that cannot be approached, preoperative 
rupture of the AVM (hematoma can 
compress the lesion, angiography is occult 
or it does not show all malformation, and 
after hematoma removal or clot dissolution 
the AVM reopens), intraoperative rupture 
(due to accidental early vein occlusion with 
severe life-threatening bleeding), difficult 
anatomy with passage vessels supplying 
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normal brain, which must be spared, 
included into a complex AVM.    
Surgery for AVMs must follow several 
principles. Always perform a large bone 
flap, providing a wide exposure, completely 
circumscribing the AVM and vessels. 
Feeding arteries must be occluded first to 
hinder blood flow into the malformation. 
Before occlusion arteries must be carefully 
inspected. Passage arteries must be spared, 
because they supply normal brain, and 
improper sacrifice causes ischemia and 
postoperative neurological deficits.  
Identification of passage arteries can be 
done by dissecting the nidus controlateral 
to vascular supply, and arteries emerging 
from the AVM are followed back to the 
nidus. Draining red veins, containing 
arterialized blood should be sacrificed last. 
If a vein must be occluded in order to 
proceed with removal, it should be 
temporary clipped first and malformation 
observed. If swallowing of the AVM occurs 
the clip must be removed and vein must be 
kept until malformation is completed 
devascularized. Small vessels are occluded 
using bipolar electrocautery, but larger ones 
necessities vascular clipping. Dissection of 
the AVM must be done into the gliotic 
plane circumscribing the nidus. Previous 
rupture facilitates dissection because it 
creates a plane between malformation and 
adjacent brain. AVM have a conic form. 
The deep part of the nidus is most difficult 
to remove because it contains small high-
pressure vessels. When the deep part is 
approached an attempt to recanalization of 
the AVM occurs. (16) After nidus removal 
is done, carefully hemostasis is achieved at a 
postoperatory estimated blood pressure.     
Difficulties of the present case are 
represented by passing middle cerebral 
artery. The sylvian fissure was split, middle 
cerebral artery trifurcation was identified, 
and the main truck was followed back to 
the nidus. Location of the AVM into the 
left temporal lobe poses a risk for 
worsening language function. Avoidance of 
language area can be done using functional 
MRI, electrocortical stimulation mapping 
and optical imaging of intrinsic signals. (2, 
3, 21) In patients with high risk of language 
deterioration awake craniotomy with 
intraoperatory language monitoring can be 
done. (3) Our patient presented dysphasia 
as a result of rupture of the AVM. She 
presented aphasia immediately after surgery 
due to postoperative edema, but she fully 
recovered language function. This 
particular location is prone for developing 
right inferior homonymous 
quadrantanopsia because the AVM comes 
in close vicinity with optic radiations. Our 
patient had no preoperatory or 
postoperatory visual field deficits. Right 
hemiparesis, in this particular location, can 
occur because the AVM is in close relation 
with the left internal capsule and during 
resection of the deep portion the capsule 
can be damaged or secondary to arterial 
occlusion. The AVM has feeding arteries 
from talamostriate arteries from left 
posterior communicating artery and left 
posterior cerebral artery, anterior choroidal 
artery and perforating branches from left 
segment M1 of the middle cerebral artery. 
Improper occlusion of passage arteries 
supplying normal brain results in motor 
deficit. In our case although all arteries of 
passage were spared, the motor deficit was a 
prior sequel from the first rupture of the 
malformation with intraparenchymatal 
capsule-lenticulo-thalamic hematoma. 
Internal capsule damage explains why the 
patient did not improve after hematoma 
removal. Other complications following 
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surgery such as rebleeding from residual 
nidus, normal perfusion pressure 
breakthrough, retrograde venous occlusion, 
ischemia, vasospasm, seizures or 
hydrocephalus did not occur in our patient.  
Because total removal of the AVM was 
not achieved with surgery we reconsidered 
adjuvant therapy. Further treatment is still 
necessary after subtotal removal because the 
risk of hemorrhage form residual nidus 
remains. By removing the part of the AVM 
circumscribing the middle cerebral artery 
Gamma knife stereotactic surgery became a 
valid therapeutic option. Resection of the 
part close to middle cerebral artery made it 
possible to exclude it from the target 
volume.  
The particularity of the presented case is 
presence of residual nidus after surgery, 
needing adjuvant Gamma knife stereotactic 
surgery. 
Conclusions  
AVMs need complex treatment 
performed in a multidisciplinary team, 
including neurosurgeon, interventional 
neuroradiologist and stereotactic 
neurosurgeon. AVMs should be addressed 
to specialized neurosurgical centers, where 
all treatment modalities are available and 
multimodal approach can be done for 
optimal results. Surgery is the treatment of 
choice in management of the AVMs. 
Reconsideration of treatment options for 
residual nidus after surgery is 
recommended. Gamma knife stereotactic 
surgery is required if a residual nidus is left 
in place following surgery. Definitive 
treatment in AVMs is mandatory because of 
the high risks of hemorrhage with high 
morbidity and mortality. 
 
Abreviations 
AVM - arteriovenous malformation 
DSA - digital subtraction angiography 
GCS - Glasglow Coma Scale 
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